You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華領醫藥將在2021年美國糖尿病協會科學年會公佈多項臨牀研究進展
格隆匯 06-21 09:19
格隆匯6月21日丨全球糖尿病創新藥領軍企業華領醫藥宣佈,將在6月25至29日線上舉行的第81屆美國糖尿病協會(ADA)科學年會中報吿其全球首創新藥多扎格列艾汀的多項臨牀研究分析數據。華領醫藥已連續8年在ADA科學年會上展示其重要臨牀成果。格隆匯瞭解到,ADA科學年會是全球規模最大且最為重要的糖尿病會議,每年都會吸引上萬名來自世界各地的糖尿病領域研究者和參與者參會並報吿、交流關於當前糖尿病研究和治療等方面的重大進展。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account